2.13 USD
-0.01 (-0.47%)
Overall FORA gets a fundamental rating of 5 out of 10. We evaluated FORA against 35 industry peers in the Health Care Technology industry. FORA has a great financial health rating, but its profitability evaluates not so good. FORA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year FORA has reported negative net income.
FORA had a positive operating cash flow in the past year.
In the past 5 years FORA reported 4 times negative net income.
In multiple years FORA reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a decent Return On Assets value of -2.07%, FORA is doing good in the industry, outperforming 68.57% of the companies in the same industry.
FORA's Return On Equity of -2.74% is fine compared to the rest of the industry. FORA outperforms 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.07% | ||
| ROE | -2.74% | ||
| ROIC | N/A |
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of FORA (55.40%) is comparable to the rest of the industry.
FORA's Gross Margin has improved in the last couple of years.
FORA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
2. Health
2.1 Basic Checks
FORA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FORA has been increased compared to 1 year ago.
The number of shares outstanding for FORA has been reduced compared to 5 years ago.
Compared to 1 year ago, FORA has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.50 indicates that FORA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.50, FORA is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
FORA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.5 |
ROIC/WACCN/A
WACC9.28%
2.3 Liquidity
FORA has a Current Ratio of 3.87. This indicates that FORA is financially healthy and has no problem in meeting its short term obligations.
FORA has a better Current ratio (3.87) than 80.00% of its industry peers.
A Quick Ratio of 3.87 indicates that FORA has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.87, FORA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.87 | ||
| Quick Ratio | 3.87 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 67.78% over the past year.
The Revenue has grown by 42.60% in the past year. This is a very strong growth!
Measured over the past years, FORA shows a small growth in Revenue. The Revenue has been growing by 5.68% on average per year.
EPS 1Y (TTM)67.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)42.6%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%65.64%
3.2 Future
FORA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.28% yearly.
Based on estimates for the next years, FORA will show a very strong growth in Revenue. The Revenue will grow by 27.73% on average per year.
EPS Next Y151%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year48.18%
Revenue Next 2Y27.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for FORA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 23.20, FORA is valued on the expensive side.
FORA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FORA is cheaper than 77.14% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of FORA to the average of the S&P500 Index (23.78), we can say FORA is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 23.2 |
4.2 Price Multiples
62.86% of the companies in the same industry are more expensive than FORA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.81 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FORA's earnings are expected to grow with 66.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.28%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for FORA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:FORA (12/12/2025, 8:00:00 PM)
2.13
-0.01 (-0.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners12.91%
Inst Owner Change-3.47%
Ins Owners44.21%
Ins Owner Change9.23%
Market Cap66.18M
Revenue(TTM)28.11M
Net Income(TTM)-852.60K
Analysts43.33
Price Target2.14 (0.47%)
Short Float %1.01%
Short Ratio0.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-95.1%
Min EPS beat(2)-100%
Max EPS beat(2)-90.2%
EPS beat(4)1
Avg EPS beat(4)-22.06%
Min EPS beat(4)-100%
Max EPS beat(4)132.68%
EPS beat(8)3
Avg EPS beat(8)-22.3%
EPS beat(12)7
Avg EPS beat(12)37.03%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.53%
Min Revenue beat(2)2.29%
Max Revenue beat(2)4.76%
Revenue beat(4)4
Avg Revenue beat(4)10.54%
Min Revenue beat(4)2.29%
Max Revenue beat(4)28.95%
Revenue beat(8)4
Avg Revenue beat(8)1.85%
Revenue beat(12)6
Avg Revenue beat(12)0.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-58%
PT rev (3m)-58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 23.2 | ||
| P/S | 2.35 | ||
| P/FCF | 46.81 | ||
| P/OCF | 46.81 | ||
| P/B | 2.13 | ||
| P/tB | 2.2 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.03
EYN/A
EPS(NY)0.09
Fwd EY4.31%
FCF(TTM)0.05
FCFY2.14%
OCF(TTM)0.05
OCFY2.14%
SpS0.9
BVpS1
TBVpS0.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.07% | ||
| ROE | -2.74% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.4% | ||
| FCFM | 5.03% |
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
F-Score7
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.87 | ||
| Quick Ratio | 3.87 | ||
| Altman-Z | 3.5 |
F-Score7
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)53.55%
Cap/Depr(5y)146.6%
Cap/Sales(3y)2.15%
Cap/Sales(5y)4.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y151%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.6%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%65.64%
Revenue Next Year48.18%
Revenue Next 2Y27.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-84.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3634.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.83%
OCF growth 3YN/A
OCF growth 5YN/A
FORIAN INC / FORA FAQ
What is the ChartMill fundamental rating of FORIAN INC (FORA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to FORA.
What is the valuation status for FORA stock?
ChartMill assigns a valuation rating of 4 / 10 to FORIAN INC (FORA). This can be considered as Fairly Valued.
How profitable is FORIAN INC (FORA) stock?
FORIAN INC (FORA) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for FORA stock?
The Earnings per Share (EPS) of FORIAN INC (FORA) is expected to grow by 151% in the next year.